The possible role of tissue-type plasminogen activator (tPA) and tPA blockers in the pathogenesis and treatment of Alzheimer’s disease

Author： Melchor Jerry Pawlak Robert Chen Zulin Strickland Sidney

Publisher： Humana Press, Inc

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.20, Iss.3, 2003-08, pp. : 287-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute enoxaparin treatment widens the therapeutic window for tPA in a mouse model of embolic stroke

By Quartermain David Li Yong-Sheng Jonas Saran

Neurological Research, Vol. 29, Iss. 5, 2007-07 ,pp. : 469-475

Maney Publishing

Access to resources Recommend Favorite

The effect of vasodilators on aspirin-induced antagonism of t-PA thrombolysis

By Bednar Martin M. Gross Cordell E. Howard Diantha B. Russell Sheila R. Ellenberger Carolyn

Neurological Research, Vol. 23, Iss. 7, 2001-10 ,pp. : 745-750

Maney Publishing

Access to resources Recommend Favorite

A simple clinical and MRI scale to predict good outcome in t-PA patients

By Kimura Kazumi Sakamoto Yuki Iguchi Yasuyuki Shibazaki Kensaku Watanabe Masao Aoki Junya Inoue Takeshi Uemura Junichi

Neurological Research, Vol. 33, Iss. 10, 2011-12 ,pp. : 1038-1043

Maney Publishing

Access to resources Recommend Favorite

Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside

By Ning MingMing

Translational Stroke Research, Vol. 1, Iss. 4, 2010-12 ,pp. : 268-275

Springer Publishing Company

Access to resources Recommend Favorite

Possible treatment targets in Alzheimer’s disease

By Pryce Roberts A. Robertson N.

Journal of Neurology, Vol. 260, Iss. 12, 2013-12 ,pp. : 3193-3196

Springer Publishing Company

Access to resources Recommend Favorite